Literature DB >> 18853458

Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10.

Cyril Goizet1, Amir Boukhris, Emeline Mundwiller, Chantal Tallaksen, Sylvie Forlani, Annick Toutain, Nathalie Carriere, Véronique Paquis, Christel Depienne, Alexandra Durr, Giovanni Stevanin, Alexis Brice.   

Abstract

Hereditary spastic paraplegias (HSP) constitute a heterogeneous group of neurodegenerative disorders characterized by slowly progressive spasticity of the lower extremities. Only a few different mutations in the SPG10 gene, KIF5A, have been described in pure dominant forms of the disease. We sequenced the motor domain of KIF5A in a large panel of 205 European HSP patients with either pure or complicated forms of the disease. We identified eight different heterozygous missense mutations, seven novels, in eight different families of French origin. Residue R280 was a mutational hot spot. Interestingly, the patients in 7/8 families had a complex phenotype, with peripheral neuropathy, severe upper limb amyotrophy (Silver syndrome-like), mental impairment, parkinsonism, deafness and/or retinitis pigmentosa as variably associated features. We report the largest series of SPG10 families described so far, which extends both the mutational spectrum of the disease and its phenotype, which now includes complicated forms of HSP. SPG10 mutations were found in 10% of our complicated forms of HSP, suggesting that mutations in KIF5A represent the major cause of complicated AD-HSP in France. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18853458     DOI: 10.1002/humu.20920

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  50 in total

1.  Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses.

Authors:  Hiroyuki Ishiura; Yuji Takahashi; Toshihiro Hayashi; Kayoko Saito; Hirokazu Furuya; Mitsunori Watanabe; Miho Murata; Mikiya Suzuki; Akira Sugiura; Setsu Sawai; Kazumoto Shibuya; Naohisa Ueda; Yaeko Ichikawa; Ichiro Kanazawa; Jun Goto; Shoji Tsuji
Journal:  J Hum Genet       Date:  2014-01-23       Impact factor: 3.172

2.  Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy.

Authors:  Ortal Barel; May Christine V Malicdan; Bruria Ben-Zeev; Judith Kandel; Hadass Pri-Chen; Joshi Stephen; Inês G Castro; Jeremy Metz; Osama Atawa; Sharon Moshkovitz; Esther Ganelin; Iris Barshack; Sylvie Polak-Charcon; Dvora Nass; Dina Marek-Yagel; Ninette Amariglio; Nechama Shalva; Thierry Vilboux; Carlos Ferreira; Ben Pode-Shakked; Gali Heimer; Chen Hoffmann; Tal Yardeni; Andreea Nissenkorn; Camila Avivi; Eran Eyal; Nitzan Kol; Efrat Glick Saar; Douglas C Wallace; William A Gahl; Gideon Rechavi; Michael Schrader; David M Eckmann; Yair Anikster
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

3.  ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia.

Authors:  Thomas Musacchio; Ann-Kathrin Zaum; Nurcan Üçeyler; Claudia Sommer; Nora Pfeifroth; Karlheinz Reiners; Erdmute Kunstmann; Jens Volkmann; Simone Rost; Stephan Klebe
Journal:  J Neurol       Date:  2016-10-13       Impact factor: 4.849

Review 4.  An emerging role for mitochondrial dynamics in schizophrenia.

Authors:  Kyle H Flippo; Stefan Strack
Journal:  Schizophr Res       Date:  2017-05-16       Impact factor: 4.939

Review 5.  Hereditary spastic paraplegias: membrane traffic and the motor pathway.

Authors:  Craig Blackstone; Cahir J O'Kane; Evan Reid
Journal:  Nat Rev Neurosci       Date:  2011-01       Impact factor: 34.870

6.  Three routes to suppression of the neurodegenerative phenotypes caused by kinesin heavy chain mutations.

Authors:  Inna Djagaeva; Debra J Rose; Angeline Lim; Chris E Venter; Katherine M Brendza; Pangkong Moua; William M Saxton
Journal:  Genetics       Date:  2012-06-19       Impact factor: 4.562

7.  A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42).

Authors:  Nina A Schlipf; Christian Beetz; Rebecca Schüle; Giovanni Stevanin; Anne Kjersti Erichsen; Sylvie Forlani; Cécile Zaros; Kathrin Karle; Stephan Klebe; Sven Klimpe; Alexandra Durr; Susanne Otto; Chantal M E Tallaksen; Olaf Riess; Alexis Brice; Peter Bauer; Ludger Schöls
Journal:  Eur J Hum Genet       Date:  2010-05-12       Impact factor: 4.246

8.  Motor protein mutations cause a new form of hereditary spastic paraplegia.

Authors:  Andrés Caballero Oteyza; Esra Battaloğlu; Levent Ocek; Tobias Lindig; Jennifer Reichbauer; Adriana P Rebelo; Michael A Gonzalez; Yasar Zorlu; Burcak Ozes; Dagmar Timmann; Benjamin Bender; Günther Woehlke; Stephan Züchner; Ludger Schöls; Rebecca Schüle
Journal:  Neurology       Date:  2014-05-07       Impact factor: 9.910

Review 9.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms.

Authors:  Patrick A Dion; Hussein Daoud; Guy A Rouleau
Journal:  Nat Rev Genet       Date:  2009-10-13       Impact factor: 53.242

10.  Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis.

Authors:  Andrea Citterio; Alessia Arnoldi; Elena Panzeri; Luciano Merlini; Maria Grazia D'Angelo; Olimpia Musumeci; Antonio Toscano; Alice Bondi; Andrea Martinuzzi; Nereo Bresolin; Maria Teresa Bassi
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.